ClinicalTrials.govpublic full text
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
brain and central nervous system tumors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 279508
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.